Y Intercept Hong Kong Ltd acquired a new stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 25,664 shares of the biopharmaceutical company’s stock, valued at approximately $571,000. Other hedge funds also recently […]